Subtype
Colorectal Carcinoma
CI-CAN-00005005CRCExplore in graph →
344 active trials5 approved drugs22 evidence items
- NCIt
- C2955
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005005CRCExplore in graph →
Clinical trials
1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (127)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03871959 | Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma(CATRIPCA) | completed | Phase 1 | 54 | Centre Leon BerardOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03871790 | Peptide-based Immunization for Colon- and and Pancreas-carcinoma(PICOP-GLOBAL) | completed | — | 50 | CENTOGENE GmbH RostockINDUSTRY | 1 | Feb 10, 2023 | clinicaltrials |
| NCT04980443 | Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors(CELTiC) | completed | N/A | 809 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 2 | Feb 1, 2023 | clinicaltrials |
| NCT03078361 | Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) | completed | N/A | 159 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT03297710 | TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05667259 | Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival | completed | — | 229 | South Valley UniversityOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05477836 | Feasibility and Safety of MiWEndo-assisted Colonoscopy(MiWEndo1) | completed | N/A | 15 | MiWEndo Solutions S.L.INDUSTRY | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05622357 | Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer | completed | Phase 2 | 51 | National Cancer Institute, EgyptOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT03078348 | Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks(IACCT) | completed | N/A | 331 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT05592873 | Oncological Impact of Lateral Nodes in Rectal Cancer(I-ONARC) | completed | — | 317 | Niguarda HospitalOTHER | 0 | Oct 25, 2022 | clinicaltrials |
| NCT02713373 | Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 45 | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT03965845 | A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 53 | Calithera Biosciences, IncINDUSTRY | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05493930 | A Lymph Node Metastasis Predictor (LN-MASTER) in Rectal Cancer | completed | — | 6,578 | Peking Union Medical CollegeOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT04208724 | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization | completed | N/A | 35 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT01896778 | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | completed | N/A | 9 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT05021172 | Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults | completed | N/A | 75 | University of California, San FranciscoOTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT03332498 | Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers | completed | Phase 1 / Phase 2 | 40 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT03958500 | The Problem of Colorectal Anastomosis Safety(ANSCRS) | completed | N/A | 60 | Vilnius UniversityOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT02218801 | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program(CLIMB) | completed | — | 219 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | May 31, 2022 | clinicaltrials |
| NCT02935309 | Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT05388513 | Evaluating Factors Affecting Survival in Colon and Rectum Cancer | completed | — | 161 | Umraniye Education and Research HospitalOTHER_GOV | 0 | May 24, 2022 | clinicaltrials |
| NCT04443985 | A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer | completed | — | 140 | Mahidol UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT03403634 | Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver | completed | Phase 2 | 19 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03688906 | AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test | completed | — | 3,275 | Freenome Holdings Inc.INDUSTRY | 2 | Mar 2, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02248805 | Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma | completed | Phase 1 | 95 | MacroGenicsINDUSTRY | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02292758 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 36 | Academic and Community Cancer Research UnitedOTHER | 1 | Jan 31, 2022 | clinicaltrials |
| NCT05162248 | Microsatellite Instability in Colorectal Cancers(MSI-CRC) | completed | — | 231 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT03949777 | Validation of Aer-O-Scope Colonoscope System Cecal Intubation | completed | N/A | 79 | GI View Ltd.INDUSTRY | 1 | Nov 18, 2021 | clinicaltrials |
| NCT05116696 | Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer | completed | — | 836 | Clinical Centre of SerbiaOTHER | 1 | Nov 11, 2021 | clinicaltrials |
| NCT05080088 | Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies(COLODETECT) | completed | — | 90 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT02347735 | Predictive Factors for Anastomotic Leakage After Colorectal Surgery(REVEAL) | completed | — | 774 | Maastricht University Medical CenterOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04003181 | The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon | completed | N/A | 64 | University of AarhusOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT00040599 | Safety Study of 90Y-hMN14 to Treat Colorectal Cancer | completed | Phase 1 / Phase 2 | 72 | Gilead SciencesINDUSTRY | 5 | Aug 19, 2021 | clinicaltrials |
| NCT00041652 | Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT04490551 | Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial | completed | N/A | 6,753 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT04607291 | Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening | completed | Phase 1 | 183 | Roswell Park Cancer InstituteOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | completed | Phase 1 | 14 | Virginia Commonwealth UniversityOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT02393755 | Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 42 | Roswell Park Cancer InstituteOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT03142516 | FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status(OPALO) | completed | Phase 2 | 20 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT03300570 | Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2021 | clinicaltrials |
| NCT01455831 | Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer(PERIOP-01) | completed | Phase 3 | 616 | Ottawa Hospital Research InstituteOTHER | 3 | May 17, 2021 | clinicaltrials |
| NCT02811497 | Study of Azacitidine and Durvalumab in Advanced Solid Tumors(METADUR) | completed | Phase 2 | 28 | University Health Network, TorontoOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT02569723 | Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy | completed | N/A | 6 | Edward KimOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT01037790 | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer | completed | Phase 2 | 304 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum(NORMAL-R) | completed | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT02127359 | Whole-Exome Sequencing (WES) of Cancer Patients | completed | — | 244 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04744792 | QoL of Colorectal Cancer Patients and Spouses | completed | — | 200 | Cihangir AkyolOTHER | 0 | Feb 9, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Feb 21, 2023source: clinicaltrials